S636-3125 Screening compound: 2-BENZYL-7-[(1-METHYL-1H-PYRAZOL-5-YL)CARBONYL]-2,5,6,7,8,9-HEXAHYDRO-3H-[1,2,4]TRIAZOLO[4,3-D][1,4]DIAZEPIN-3-ONE

S636-3125 Screening compound: 2-BENZYL-7-[(1-METHYL-1H-PYRAZOL-5-YL)CARBONYL]-2,5,6,7,8,9-HEXAHYDRO-3H-[1,2,4]TRIAZOLO[4,3-D][1,4]DIAZEPIN-3-ONE
S636-3125 Screening compound: 2-BENZYL-7-[(1-METHYL-1H-PYRAZOL-5-YL)CARBONYL]-2,5,6,7,8,9-HEXAHYDRO-3H-[1,2,4]TRIAZOLO[4,3-D][1,4]DIAZEPIN-3-ONE alternative view

Chemical Structure Depiction of ChemDiv screening compound S636-3125
2-BENZYL-7-[(1-METHYL-1H-PYRAZOL-5-YL)CARBONYL]-2,5,6,7,8,9-HEXAHYDRO-3H-[1,2,4]TRIAZOLO[4,3-D][1,4]DIAZEPIN-3-ONE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S636-3125

Molecular Formula

C18H20N6O2 (C18 H20 N6 O2)

Compound Name

2-BENZYL-7-[(1-METHYL-1H-PYRAZOL-5-YL)CARBONYL]-2,5,6,7,8,9-HEXAHYDRO-3H-[1,2,4]TRIAZOLO[4,3-D][1,4]DIAZEPIN-3-ONE

IUPAC name

n/a

SMILES

Cn1nccc1C(N(CCC1=NN2Cc3ccccc3)CCN1C2=O)=O

InChI

InChI=1S/C18H20N6O2/c1-21-15(7-9-19-21)17(25)22-10-8-16-20-24(18(26)23(16)12-11-22)13-14-5-3-2-4-6-14/h2-7,9H,8,10-13H2,1H3

InChI Key

OUBKXHYMHBTSEY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29017334

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

352.4

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

0.978

Distribution Coefficient, logD

0.978

Water Solubility, LogSw

-1.55

Polar Surface Area

63.622

Acid Dissociation Constant (pKa)

22.29

Base Dissociation Constant (pKb)

1.56

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

S636-3125 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with S636-3125 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S636-3125?
Check Price and Availability of S636-3125, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S636-3125 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S636-3125
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S636-3125
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S636-3125 available by request